These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35326836)

  • 21. Ceftazidime-avibactam in the treatment of infections from carbapenem-resistant Klebsiella pneumoniae: Ceftazidime-avibactam against CR-KP infections.
    Gu J; Xu J; Zuo TT; Chen YB
    J Glob Antimicrob Resist; 2021 Sep; 26():20-25. PubMed ID: 34020072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aztreonam plus ceftazidime-avibactam as treatment of NDM-1-producing Klebsiella pneumoniae bacteraemia in a neutropenic patient: Last resort therapy?
    Bocanegra-Ibarias P; Camacho-Ortiz A; Garza-González E; Flores-Treviño S; Kim H; Perez-Alba E
    J Glob Antimicrob Resist; 2020 Dec; 23():417-419. PubMed ID: 33212285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New options for bloodstream infections caused by colistin- or ceftazidime/avibactam-resistant Klebsiella pneumoniae.
    Yu W; Luo Q; Shen P; Chen Y; Xu H; Xiao Y; Qiu Y
    Int J Antimicrob Agents; 2021 Dec; 58(6):106458. PubMed ID: 34706255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic diversity and in vitro activity of ceftazidime/avibactam and aztreonam/avibactam against imipenem-resistant Enterobacteriaceae isolates in Southwest China: A single-centre study.
    Wei J; Zou C; Wang D; Huang A; Niu S
    J Glob Antimicrob Resist; 2020 Sep; 22():448-451. PubMed ID: 32387260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing
    Tumbarello M; Raffaelli F; Cascio A; Falcone M; Signorini L; Mussini C; De Rosa FG; Losito AR; De Pascale G; Pascale R; Giacobbe DR; Oliva A; Farese A; Morelli P; Tiseo G; Meschiari M; Del Giacomo P; Montagnani F; Fabbiani M; Vargas J; Spanu T; Bassetti M; Venditti M; Viale P
    JAC Antimicrob Resist; 2022 Mar; 4(1):dlac022. PubMed ID: 35265842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Carbapenem-resistant
    Zou C; Wei J; Shan B; Chen X; Wang D; Niu S
    Infect Drug Resist; 2020; 13():3563-3568. PubMed ID: 33116675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing Characteristics and
    Mavroidi A; Katsiari M; Likousi S; Palla E; Roussou Z; Nikolaou C; Mathas C; Merkouri E; Platsouka ED
    Microb Drug Resist; 2020 Jan; 26(1):28-37. PubMed ID: 31386596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in
    Giddins MJ; Macesic N; Annavajhala MK; Stump S; Khan S; McConville TH; Mehta M; Gomez-Simmonds A; Uhlemann AC
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of Hypervirulent Ceftazidime/Avibactam-Resistant
    Li D; Liao W; Huang HH; Du FL; Wei DD; Mei YF; Long D; Wan LG; Liu Y; Zhang W
    Infect Drug Resist; 2020; 13():2673-2680. PubMed ID: 32821131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of Ceftazidime-Avibactam, Meropenem-Vaborbactam, and Imipenem/Cilastatin-Relebactam to Target
    Hayden DA; White BP; Bennett KK
    J Pharm Technol; 2020 Oct; 36(5):202-210. PubMed ID: 34752560
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful treatment of ceftazidime/avibactam combined with aztreonam in the NDM-producing Klebsiella pneumoniae bloodstream and intestinal infections in a NK/T lymphoma patient with agranulocytosis during autologous hematopoietic stem cell transplantation: a case report.
    Liu S; Lin Q; Ouyang L; Zhou C; Wang H
    Eur J Clin Microbiol Infect Dis; 2022 Nov; ():1-4. PubMed ID: 36371600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simple disk pre-diffusion test to predict in vitro aztreonam/avibactam activity against NDM-producing Klebsiella pneumoniae complex.
    Lima KO; de Lima AV; Rocha DADC; Sampaio SCF; Cappellano P; Sampaio JLM
    J Glob Antimicrob Resist; 2022 Mar; 28():49-52. PubMed ID: 34936924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of aztreonam/avibactam against a global collection of Klebsiella pneumoniae collected from defined culture sources in 2016 and 2017.
    Esposito S; Stone GG; Papaparaskevas J
    J Glob Antimicrob Resist; 2021 Mar; 24():14-22. PubMed ID: 32841721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to ceftazidime/avibactam in infections and colonisations by KPC-producing Enterobacterales: a systematic review of observational clinical studies.
    Di Bella S; Giacobbe DR; Maraolo AE; Viaggi V; Luzzati R; Bassetti M; Luzzaro F; Principe L
    J Glob Antimicrob Resist; 2021 Jun; 25():268-281. PubMed ID: 33895414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment.
    Gaibani P; Campoli C; Lewis RE; Volpe SL; Scaltriti E; Giannella M; Pongolini S; Berlingeri A; Cristini F; Bartoletti M; Tedeschi S; Ambretti S
    J Antimicrob Chemother; 2018 Jun; 73(6):1525-1529. PubMed ID: 29566151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Last resort beta-lactam antibiotics for treatment of New-Delhi Metallo-Beta-Lactamase producing Enterobacterales and other Difficult-to-Treat Resistance in Gram-negative bacteria: A real-life study.
    Larcher R; Laffont-Lozes P; Roger C; Doncesco R; Groul-Viaud C; Martin A; Loubet P; Lavigne JP; Pantel A; Sotto A
    Front Cell Infect Microbiol; 2022; 12():1048633. PubMed ID: 36544909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thoracic aorta graft infection by avibactam-resistant KPC-producing
    Belati A; Novara R; Bavaro DF; Procopio A; Fico C; Diella L; Romanelli F; Stolfa S; Mosca A; Di Gennaro F; Saracino A
    Infez Med; 2022; 30(2):277-284. PubMed ID: 35693053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced Ceftazidime-Avibactam Susceptibility in KPC-Producing
    Cui X; Shan B; Zhang X; Qu F; Jia W; Huang B; Yu H; Tang YW; Chen L; Du H
    Front Microbiol; 2020; 11():1365. PubMed ID: 32655534
    [No Abstract]   [Full Text] [Related]  

  • 39. Searching for the Optimal Treatment for Metallo- and Serine-β-Lactamase Producing Enterobacteriaceae: Aztreonam in Combination with Ceftazidime-avibactam or Meropenem-vaborbactam.
    Biagi M; Wu T; Lee M; Patel S; Butler D; Wenzler E
    Antimicrob Agents Chemother; 2019 Sep; 63(12):. PubMed ID: 31570403
    [No Abstract]   [Full Text] [Related]  

  • 40. Emergence of transferable ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae due to a novel CMY AmpC β-lactamase in China.
    Xu M; Zhao J; Xu L; Yang Q; Xu H; Kong H; Zhou J; Fu Y
    Clin Microbiol Infect; 2022 Jan; 28(1):136.e1-136.e6. PubMed ID: 34044150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.